What is the recommended treatment for a patient with bacterial conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bacterial Conjunctivitis

For mild bacterial conjunctivitis, prescribe a 5-7 day course of broad-spectrum topical antibiotic applied 4 times daily, choosing the most convenient or least expensive option since no evidence shows superiority of any particular agent. 1, 2

Initial Assessment and Diagnosis

  • Bacterial conjunctivitis typically presents with marked inflammation, purulent discharge, and sometimes pain, often with morning crusting and difficulty opening eyelids 3, 4
  • Examine for swollen preauricular or submandibular lymph nodes, which may indicate bacterial infection 3
  • For uncomplicated mild cases, cultures are NOT routinely needed and diagnosis can be made clinically 1
  • Obtain conjunctival cultures and Gram staining before treatment in moderate to severe cases (copious purulent discharge, pain, marked inflammation), especially if gonococcal infection is suspected 3, 1, 2

Treatment Algorithm by Severity

Mild Bacterial Conjunctivitis

  • Apply broad-spectrum topical antibiotic 4 times daily for 5-7 days 3, 1, 2
  • This accelerates clinical and microbiological remission in days 2-5, reduces transmissibility, and allows earlier return to school/work 3, 1
  • Choose the most convenient or least expensive option as no clinical evidence suggests superiority of any particular antibiotic 1, 2

Recommended first-line options:

  • Aminoglycosides (tobramycin, gentamicin) - effective against common bacterial pathogens 3, 1
  • Polymyxin B/trimethoprim - broad-spectrum coverage 1, 5
  • Bacitracin ointment - apply 1-3 times daily directly into conjunctival sac 6
  • Erythromycin - remains a viable option per WHO endorsement 1

Moderate to Severe Bacterial Conjunctivitis

  • Reserve fluoroquinolones (moxifloxacin, gatifloxacin, ofloxacin, ciprofloxacin) for moderate to severe cases with copious purulent discharge, pain, and marked inflammation 1
  • Fluoroquinolones are particularly important for contact lens wearers at higher risk for Pseudomonas infection 1
  • Fourth-generation fluoroquinolones (moxifloxacin, gatifloxacin) have better gram-positive coverage, including some MRSA strains 1
  • Guide antibiotic choice by culture and Gram stain results 2

Special Cases Requiring Systemic Therapy

Gonococcal Conjunctivitis

  • Requires systemic antibiotic therapy, NOT topical treatment alone 3, 1, 2
  • Add saline lavage to promote comfort and faster resolution 1
  • Daily follow-up until resolution is mandatory 2
  • Hospitalization may be necessary for severe cases and is mandatory for neonatal conjunctivitis 1

Chlamydial Conjunctivitis

  • Requires systemic antibiotic therapy, especially in infants who may have infection at other sites 3, 1, 2
  • For neonates: erythromycin base or ethylsuccinate 50 mg/kg/day divided into 4 doses for 14 days (96% clinical cure rate, 97% microbiological cure rate) 1
  • No evidence supports additional topical therapy beyond systemic treatment 1
  • Follow-up evaluation is important as treatment failure occurs in up to 19% of cases 2

MRSA Conjunctivitis

  • May require compounded topical vancomycin, as MRSA is resistant to many commercially available topical antibiotics including aminoglycosides and fluoroquinolones 1

Alternative Treatment Option

  • Povidone-iodine 1.25% ophthalmic solution may be as effective as topical antibiotics and can be considered when access to antibiotics is limited 3, 1, 2

Critical Pitfalls to Avoid

  • Never use topical corticosteroids unless under close supervision, as they may prolong bacterial shedding and worsen infection 3
  • Avoid prescribing antibiotics for viral conjunctivitis, which promotes unnecessary costs and resistance 1
  • Do not use fluoroquinolones as first-line therapy for mild cases - save them for severe infections due to broad spectrum activity and resistance concerns 7
  • Increasing bacterial resistance is a concern, particularly with MRSA 3, 1, 2
  • Poor adherence to frequent administration regimens contributes to treatment failure 1, 8

Follow-up Protocol

  • Advise patients to return if no improvement after 3-4 days of treatment 3, 1, 2
  • At follow-up, perform interval history, visual acuity measurement, and slit-lamp biomicroscopy 3, 1

When to Refer to Ophthalmology

Immediate referral indicated for: 3, 1

  • Visual loss
  • Moderate or severe pain
  • Severe purulent discharge
  • Corneal involvement
  • Conjunctival scarring
  • Lack of response to therapy
  • Recurrent episodes
  • Neonates with HSV infection (life-threatening)

Infection Control Measures

  • Counsel patients on frequent hand washing to prevent spread 1
  • Avoid sharing personal items 3
  • For children with gonococcal or chlamydial infections, consider the possibility of sexual abuse 1, 2

References

Guideline

Treatment of Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Bacterial Conjunctivitis: Frequency and Duration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Infectious Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Bacterial conjunctivitis--diagnosis and therapy update].

Klinische Monatsblatter fur Augenheilkunde, 2012

Research

Limitations of current antibiotics for the treatment of bacterial conjunctivitis.

Optometry and vision science : official publication of the American Academy of Optometry, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.